ImmunityBio, Inc. financial data

Symbol
IBRX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
3530 John Hopkins Court, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
NantKwest, Inc. (to 3/8/2021), Conkwest, Inc. (to 7/13/2015), ZelleRx Corp (to 10/9/2009)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 381 % +1158%
Debt-to-equity -163 % +4.66%
Return On Equity 86.5 % -3.81%
Return On Assets -137 % -7.02%
Operating Margin -115K % -82.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 697M shares +4.36%
Common Stock, Shares, Outstanding 697M shares +4.36%
Entity Public Float 316M USD +4.57%
Common Stock, Value, Issued 70K USD +4.48%
Weighted Average Number of Shares Outstanding, Basic 696M shares +39.6%
Weighted Average Number of Shares Outstanding, Diluted 698M shares +40%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 302K USD -48.5%
Revenue from Contract with Customer, Excluding Assessed Tax 6.11M USD +7346%
Research and Development Expense 206M USD -13.6%
Operating Income (Loss) -360M USD +0.44%
Nonoperating Income (Expense) -228M USD -135%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -588M USD -28.2%
Income Tax Expense (Benefit) -40K USD -218%
Net Income (Loss) Attributable to Parent -588M USD -28.3%
Earnings Per Share, Basic -0.89 USD/shares +14.4%
Earnings Per Share, Diluted -0.91 USD/shares +12.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 112M USD -37.1%
Marketable Securities, Current 18.4M USD +55.5%
Accounts Receivable, after Allowance for Credit Loss, Current 4.18M USD
Inventory, Net 1.96M USD
Other Assets, Current 1.37M USD -68.8%
Assets, Current 163M USD -24.1%
Property, Plant and Equipment, Net 139M USD -8.37%
Operating Lease, Right-of-Use Asset 34.9M USD -2.41%
Intangible Assets, Net (Excluding Goodwill) 16.1M USD -15.4%
Goodwill 910K USD
Other Assets, Noncurrent 3.64M USD +6.3%
Assets 365M USD -15.7%
Accounts Payable, Current 33.6M USD +241%
Accrued Liabilities, Current 43.6M USD -32.8%
Liabilities, Current 61M USD -32.5%
Deferred Income Tax Liabilities, Net 162K USD -4.71%
Operating Lease, Liability, Noncurrent 36.8M USD -6.49%
Other Liabilities, Noncurrent 705K USD +51%
Liabilities 1.11B USD +31.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 103K USD -87%
Retained Earnings (Accumulated Deficit) -3.32B USD -21.5%
Stockholders' Equity Attributable to Parent -745M USD -81%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -744M USD -81.2%
Liabilities and Equity 365M USD -15.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -107M USD -26.9%
Net Cash Provided by (Used in) Financing Activities 10.2M USD -86.7%
Net Cash Provided by (Used in) Investing Activities -35.6M USD -320%
Common Stock, Shares Authorized 1.35B shares +50%
Common Stock, Shares, Issued 697M shares +4.36%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -132M USD -719%
Interest Paid, Excluding Capitalized Interest, Operating Activities 23.9M USD +54.1%
Deferred Tax Assets, Valuation Allowance 648M USD +31.9%
Deferred Tax Assets, Gross 683M USD +30.4%
Operating Lease, Liability 43.8M USD +0.27%
Depreciation 15.8M USD -7.06%
Payments to Acquire Property, Plant, and Equipment 1.26M USD -85%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -588M USD +9.64%
Lessee, Operating Lease, Liability, to be Paid 58.6M USD -4.44%
Property, Plant and Equipment, Gross 235M USD +1.02%
Operating Lease, Liability, Current 7.03M USD +61.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9.73M USD -4.92%
Lessee, Operating Lease, Liability, to be Paid, Year One 11.6M USD +13.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 14.3M USD -15.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.98M USD +7.8%
Deferred Tax Assets, Operating Loss Carryforwards 421M USD +16.1%
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 35.5M USD +118%
Lessee, Operating Lease, Liability, to be Paid, Year Four 9.25M USD +22.5%
Operating Lease, Payments 2.38M USD -25%
Amortization of Intangible Assets 2M USD +5.26%
Depreciation, Depletion and Amortization 4.56M USD -2.69%
Share-based Payment Arrangement, Expense 38.2M USD -16.6%
Interest Expense 121M USD -3.91%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%